BillionToOne is a next-generation molecular diagnostics company dedicated to developing powerful and accurate diagnostic tests that are accessible to all. Our innovative QCT molecular counting technology significantly enhances the resolution of disease detection using cell-free DNA by over a thousandfold. This groundbreaking technology is integral to our product offerings, including one of our flagship products, Unity Complete™, the only non-invasive prenatal screen capable of assessing fetal risk for both common recessive conditions and aneuploidies from a single maternal blood sample. Leveraging the same molecular counting technology, we've expanded our impact into oncology in 2023 with a pioneering liquid biopsy test, Northstar, that combines treatment selection with monitoring. To date, over 500,000 patients have benefited from our innovative and precise diagnostic tests, and our Annual Recurring Revenue (ARR) has grown from $0 to $125 million in the last ~4 years.
BillionToOne has successfully raised close to $400 million in funding, with a notable $130 million Series D round completed in June 2024, resulting in a company valuation of over $1 billion. This funding has come from prestigious global institutional investors, including Hummingbird, Adams Street Partners, Neuberger Berman, Baillie Gifford, and Premji Invest. BillionToOne has recently been recognized by Forbes as one of America's Best Startup Employers for 2024, highlighting the company's exceptional work environment and commitment to innovation.
Our team has grown significantly and we now proudly employ over 400 highly skilled individuals. Despite substantial growth, we have successfully maintained the unique culture that has defined BillionToOne from inception, continuing to cultivate a team that is not only diverse and passionate but also innovative. Headquartered in Menlo Park, California, with an additional facility in Union City, California, BillionToOne remains at the forefront of significant advances in molecular diagnostics, evidenced by the recent announcement of clinical outcomes data for its Unity Fetal Risk Screen and new advancements in cancer diagnostics. For more detailed information about BillionToOne and its groundbreaking work, please visit our website at www.billiontoone.com.
We are seeking a highly skilled and motivated Senior Data Scientist, Commercial Analytics to join our team. This individual will be responsible for data analysis, reporting, and insight generation in support of our commercial strategy. The ideal candidate will have a strong background in data manipulation, data retrieval, and advanced analytical techniques. This role requires hands-on expertise in Python and SQL, as well as the ability to work with data from multiple sources to drive insightful analyses.
Responsibilities:
- Conduct in-depth data analysis to support commercial decision-making, uncovering insights into market trends, product performance, and customer behavior.
- Collaborate with stakeholders to define key metrics and build comprehensive analytics solutions that address specific business needs.
- Retrieve and integrate data from various sources and formats to create cohesive datasets for analysis.
- Leverage AI tools and machine learning techniques to automate and enhance data processing, creating more efficient workflows.
- Develop and maintain dashboards, reports, and visualizations to communicate insights clearly to both technical and non-technical audiences.
- Collaborate with cross-functional teams, including Sales, Marketing, and Product Development, to inform and support business strategies.
Requirements:
- Excellent communication skills and ability to work collaboratively with cross-functional teams.
- PhD in a Bioscience related field.
- Strong experience in Python and data manipulation tools (e.g., SQL, R).
- Ability to retrieve and munge data from disparate sources and formats
- Experience with clinical data.
- Proficiency in using AI tools to enhance data processing and analysis.
- Strong problem-solving skills and ability to troubleshoot complex queries.
Nice-To-Haves:
- Familiarity with data warehousing and ETL processes.
- Experience with data visualization tools, such as Tableau.
- Experience with AWS services (e.g., S3, Batch) and workflow orchestration tools like Airflow.
- 1-2 years of experience as a Data Scientist or in a related analytical role, with a demonstrated willingness to learn and take on new challenges.
Benefits And Perks:
- Working with a team of ‘rockstars’ who bring out the best in everyone
- Open, transparent culture that includes weekly Town Hall meetings
- The ability to indirectly or directly change the lives of hundreds of thousand patients
- Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered at 80%
- Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
- Retirement savings program including a 4% Company match
- Free daily on-site lunches provided from top eateries
- Latest and greatest hardware (laptop, lab equipment, facilities)
- A variety of perks on campus (state of the art gym, restaurant)
- Free on-site EV charging (compatible with all EVs, including Tesla)
At BillionToOne, we are proud to offer a combination of a (1) base pay range (actual amount offered is based on experience and salary/equity options split that the candidate chooses), (2) generous equity options offering, (3) corporate bonus program, on top of (4) industry leading company benefits (free healthcare options, 401k match, very generous fully paid parental leave, etc.).
For this position, we offer a total compensation package of up to $220,000 per year, including a base pay range of $155,000-$175,000 per year.
BillionToOne is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Top Skills
What We Do
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending molecular counter platform is the only technology platform that can accurately count the DNA molecules at the single-count level.
